Shadi Yaghi: Evidence Supports DOACs as an Alternative to VKAs for Cerebral Venous Thrombosis
Shadi Yaghi, Professor and Chair of Neurology at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center, shared a post on X about a recent article he and his colleagues co-authored, published in Stroke, adding:
“More evidence supporting the use of DOACs for the treatment of cerebral venous thrombosis except when APLS is present.
In this large meta-analysis, VKA and DOACs were equivalent, regardless of DOAC type.”
Title: Comparison of DOAC Versus VKA for Cerebral Venous Thrombosis: A Systematic Review and Meta-Analysis
Authors: Farhan Khan, Muhammad Afnan Ashraf, Dalia Chahien, Lauren Fletcher, Saad Chaudry, Talib Shah, Skylar Lewis, Liqi Shu, Ana-Lucia Garcia Guarniz, Thalia S. Field, Thanh N. Nguyen, Mark Cort, Karen Furie, Jose M. Ferro, Shadi Yaghi, Jonathan Coutinho
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 26, 2026, 14:15Kale Gubae: Comparing the Effectiveness and Safety of Warfarin and Rivaroxaban in Atrial Fibrillation
-
Oct 26, 2026, 14:06Mokhtar Tazik: Evidence-Based Regulation to Strengthen Plasma Supply and Patient Safety
-
Oct 26, 2026, 13:57Gladys Delancey: Spotting the Warning Signs of Vein Disease
-
Oct 26, 2026, 13:36Kefah Mokbel: Targeted Breast Cancer Therapies Linked to Increased Thrombotic Risk
-
Oct 26, 2026, 13:32Jorge Enrique: Beyond Fibrin Targeting New Strategies for Thrombolysis
-
Oct 26, 2026, 13:23Priya Sriskandarajah: Treatment Challenges in Elderly and Frail Patients with Philadelphia-Negative MPNs
-
Oct 26, 2026, 12:48Milica Kuzmanovska: Latest Updates in PV, ET, and Myelofibrosis Management
-
Oct 26, 2026, 12:38Hytham Abu Aagla: Daratumumab and Transfusion Compatibility
-
Oct 26, 2026, 10:17Pankaj K.: Genetic Hemolytic Anemias Common Types, Symptoms and Long-Term Management